4.8 Editorial Material

Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge?

期刊

CELL METABOLISM
卷 20, 期 2, 页码 197-199

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2014.07.013

关键词

-

资金

  1. NIDDK NIH HHS [P01 DK049210] Funding Source: Medline

向作者/读者索取更多资源

Metformin is the most widely prescribed drug to lower glucose in type II diabetics, yet its mechanism of action remains controversial. A new study reveals that metformin inhibits mitochondrial glycerol-3-phosphate dehydrogenase, triggering reduction of the cytosolic NADH/NAD(+) pool and impaired utilization of redox-dependent substrates for gluconeogenesis (Madiraju et al., 2014).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据